Kopran Limited
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides d… Read more
Kopran Limited - Asset Resilience Ratio
Kopran Limited (KOPRAN) has an Asset Resilience Ratio of 5.39% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how Kopran Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Kopran Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹371.35 Million | 4.57% |
| Short-term Investments | ₹66.93 Million | 0.82% |
| Total Liquid Assets | ₹438.28 Million | 5.39% |
Asset Resilience Insights
- Limited Liquidity: Kopran Limited maintains only 5.39% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Kopran Limited Industry Peers by Asset Resilience Ratio
Compare Kopran Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367 |
Drug Manufacturers - General | 32.14% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.00% |
|
PharmGen Science Inc
KO:004720 |
Drug Manufacturers - General | 0.16% |
Annual Asset Resilience Ratio for Kopran Limited (2004–2025)
The table below shows the annual Asset Resilience Ratio data for Kopran Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.78% | ₹65.85 Million | ₹8.44 Billion | +0.12pp |
| 2024-03-31 | 0.66% | ₹48.75 Million | ₹7.43 Billion | -0.17pp |
| 2023-03-31 | 0.83% | ₹53.70 Million | ₹6.50 Billion | -7.55pp |
| 2022-03-31 | 8.38% | ₹511.95 Million | ₹6.11 Billion | +6.07pp |
| 2021-03-31 | 2.31% | ₹101.53 Million | ₹4.39 Billion | +2.31pp |
| 2020-03-31 | 0.00% | ₹40.00K | ₹3.71 Billion | +0.61pp |
| 2019-03-31 | -0.61% | ₹-21.34 Million | ₹3.52 Billion | -0.11pp |
| 2018-03-31 | -0.50% | ₹-15.63 Million | ₹3.15 Billion | -0.72pp |
| 2017-03-31 | 0.23% | ₹6.72 Million | ₹2.99 Billion | +0.22pp |
| 2016-03-31 | 0.00% | ₹40.25K | ₹2.64 Billion | +0.00pp |
| 2015-03-31 | 0.00% | ₹40.25K | ₹2.75 Billion | +0.00pp |
| 2014-03-31 | 0.00% | ₹40.25K | ₹2.99 Billion | 0.00pp |
| 2013-03-31 | 0.00% | ₹40.25K | ₹2.63 Billion | +0.98pp |
| 2012-03-31 | -0.98% | ₹-24.50 Million | ₹2.50 Billion | -1.75pp |
| 2006-03-31 | 0.77% | ₹33.42 Million | ₹4.34 Billion | +0.22pp |
| 2005-03-31 | 0.55% | ₹23.30 Million | ₹4.23 Billion | -0.02pp |
| 2004-03-31 | 0.57% | ₹27.04 Million | ₹4.77 Billion | -- |